Abstract
Among the technologies currently available, continuous flow chemistry can aid the synthesis of pharmaceutical actives by integrating multiple steps, and by direct scale up of reactions. In 2017 we developed an integrated flow synthesis for the rapid generation of 3-thio-1,2,4-triazoles from hydrazides and isothiocyanates. Lesinurad is a uric acid transporter protein (URAT1) inhibitor appr…